The drug treats fast-growing, deadly brain cancers with no effective treatment.
Agreement will expand clinical trials of glioblastoma drug
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.
OMRF, Stephenson Cancer Center begin tests of experimental compound
Cutting off avenues for growth is key to killing tumors.
For many cancers, the odds of survival now are better than ever and going up.